AND

Clemastine fumarate syrup

Profile

Contact Information

Currently Enrolling Trials

    Show More

    General Information

    Clemastine Fumarate Syrup 0.5 mg/5 ml, a generic version of Novartis' Tavist Syrup, has been approved for the treatment of allergic rhinitis.

    Approval Date: 1998-03-01
    Company Name: Morton Grove Pharmaceuticals
    Back to Listings

    Upcoming Events

    Featured Products

    Featured Stories

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here